Scholarly productivity of non–pharmacy practice faculty in U.S. schools and colleges of pharmacy, 2019–2023 Authors: Osama A. Shoair, Sierra Pollard, Faith Fosuhene-Apenteng, Michael Pimentel-Galvan, Abrar Elagami, May H. Abdel Aziz Published: 2026 ABSTRACT PurposeScholarly productivity is central to academic advancement, institutional benchmarking, and accreditation in pharmacy education. This study evaluated the national scholarly productivity among non–pharmacy practice (NPP) faculty in U.S. schools and colleges of pharmacy and assessed variation in publication output across faculty and nppinstitutional characteristics.MethodsA retrospective bibliometric analysis was conducted between January 2019 and December 2023. Faculty were identified using the American Association of Colleges of Pharmacy Roster of Faculty and Professional Staff and classified as biomedical and pharmaceutical sciences (BPS) or social and administrative sciences (SAS). Publications were retrieved from Web of Science and characterized by type and scope.ResultsThe analysis included 1613 NPP faculty from 142 U.S. schools and colleges of pharmacy. The mean annual publication rate was 3.43 ± 4.35 per faculty member (median 2; IQR 0.8–4.6). Publication productivity was skewed, with 15% of faculty producing 50% of all publications. BPS faculty demonstrated higher productivity (median 2.8; IQR 1.0–7.8) than SAS faculty (median 1.8; IQR 0.6–4.2). Original research articles comprised 67.7% of publications, followed by meeting abstracts/proceedings (16.6%) and narrative reviews (8.9%). Most publications were BPS-focused (72.5%), followed by SAS/health economics and outcomes research/clinical trials (25.5%) and scholarship of teaching and learning (2.1%). Increased publication productivity was noted among senior academic ranks, at public institutions, within health science center-affiliated schools, and at institutions offering graduate programs and receiving higher levels of extramural funding.ConclusionThese findings provide contemporary national benchmarks for NPP scholarly productivity and highlight the influence of faculty and institutional characteristics on publication output. Introduction Scholarly productivity in academic pharmacy Scholarly productivity is essential for academic success and for sustaining a strong institutional reputation in higher education. It serves as a central mechanism for advancing knowledge, fostering innovation, and meeting accreditation expectations. Within pharmacy education, faculty scholarly productivity plays a critical role in institutional benchmarking, faculty evaluation, and academic advancement. Peer-reviewed publications remain the most consistently reported and comparable indicator of scholarly productivity across academic pharmacy, offering a standardized framework for evaluating research output across disciplines and institutions. Existing research has demonstrated substantial variability in publication productivity across disciplines, academic ranks, and institutional environments, with higher output generally observed in settings characterized by robust research infrastructure and support. However, much of the published literature examining faculty scholarly productivity relies on data from earlier periods, limiting its utility for informing contemporary benchmarking in academic pharmacy. Prior research on pharmacy faculty scholarly productivity Prior studies examining faculty scholarly productivity in U.S. schools and colleges of pharmacy have primarily focused on pharmacy practice faculty. Differences in scholarly productivity between public and private institutions have been reported in several studies.1, 2, 3 Variability in faculty scholarly output related to institutional affiliation with a health science center (HSC) has also been examined.2, 4 Additional studies evaluated the influence of the presence of graduate programs or doctoral training on faculty scholarly productivity.2, 3 Institutional research funding has also been examined as a factor associated with scholarly productivity.2 Faculty-level factors associated with scholarly productivity have included academic rank and gender,1 as well as tenure status and research effort allocation.3 In contrast, Coleman et al. (2007) provided an earlier descriptive evaluation of pharmacy practice faculty scholarly productivity without stratifying productivity by faculty or institutional characteristics.5 Although these studies provide valuable insight into scholarly productivity within pharmacy practice faculty, their findings cannot be generalized to non-pharmacy practice (NPP) faculty. NPP faculty—encompassing biomedical and pharmaceutical sciences (BPS) and social and administrative sciences (SAS)—operate under research models that differ structurally from those of pharmacy practice faculty, whose roles are often more clinically and instructionally intensive. Differences in research expectations, funding mechanisms, collaborative structures, and time allocation limit the applicability of pharmacy practice–derived benchmarks to NPP faculty. These distinctions highlight the need for integrated, nationally representative assessments of scholarly productivity that are specific to NPP faculty across diverse institutional settings. Studies examining scholarly productivity within NPP disciplines have provided useful benchmarks, but these have generally been limited to specific disciplines or institutional contexts. Earlier work examining the scholarly productivity of faculty in the basic and pharmaceutical sciences focused primarily on research-intensive U.S. schools and colleges of pharmacy.6, 7 Other studies examined NPP scholarly productivity in non-research-intensive settings, including pharmaceutical sciences faculty and SAS faculty.8, 9 Taken together, this body of work in NPP faculty highlights a fragmented literature in which discipline-specific cohorts and institution-restricted samples constrain generalizability and limit the availability of integrated, national benchmarks for NPP faculty scholarly productivity. Moreover, like the pharmacy practice literature, many of these studies draw on publication data from earlier periods, further limiting their relevance to current scholarly expectations across diverse institutional contexts. These gaps underscore the need for a contemporary, nationally representative evaluation of scholarly productivity among NPP faculty. Study significance and purpose Establishing clear, nationally relevant benchmarks for scholarly productivity among NPP faculty is essential for promoting transparency and consistency in academic evaluation. Such reference points enable faculty to contextualize their scholarly output relative to peers with comparable disciplinary and institutional profiles, which is particularly valuable during promotion and tenure deliberations. At the institutional level, discipline- and context-specific benchmarks facilitate equitable evaluation across heterogeneous faculty roles and research environments, accounting for differences such as public versus private status, HSC affiliation, funding structures, and the presence of graduate programs. Collectively, these benchmarks support both individual faculty development and institutional accountability by grounding expectations for scholarly productivity in empirically derived national patterns. The present study provides a comprehensive, nationwide evaluation of scholarly productivity among NPP faculty across all U.S. schools and colleges of pharmacy. Using a recent, five-year observation window (January 1, 2019–December 31, 2023), this study aims to (1) quantify total and annualized scholarly productivity by measuring the volume, type, and scope of peer-reviewed publications produced by NPP faculty, and (2) examine how faculty demographic, institutional, and regional characteristics are associated with variations in publication productivity among NPP faculty. By offering nationally representative benchmarks across BPS and SAS disciplines, this study contributes to a more complete understanding of scholarship in academic pharmacy and provides empirically grounded reference points to inform faculty development, institutional evaluation, and policy discussions. Methods Study design This study employed a retrospective bibliometric analysis to examine scholarly productivity among NPP faculty at U.S. schools and colleges of pharmacy. Publication output was quantified, and patterns were analyzed across faculty and institutional characteristics over a five-year period spanning January 1, 2019, to December 31, 2023. Study population and eligibility The study population consisted of NPP faculty employed at U.S. schools and colleges of pharmacy during the study period. Faculty were identified using the American Association of Colleges of Pharmacy (AACP) Roster of Faculty and Professional Staff, and their appointment status and disciplinary classification were confirmed through cross-referencing with publicly available institutional directories.10 NPP faculty disciplines were categorized as BPS or SAS in accordance with the disciplinary framework outlined in ACPE Standards Appendix 1.11 Faculty discipline classifications were operationalized using the “Discipline” field in the AACP Faculty and Professional Staff Roster.10 SAS faculty were identified using the roster category “social and administrative science”, while BPS faculty included the categories "biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics". Faculty were eligible for inclusion if they held an academic rank of Assistant Professor, Associate Professor, or Professor. Faculty serving as department chairs or heads were retained in the analytic sample because these positions are typically held concurrently with regular faculty appointments and commonly involve continued expectations for scholarly productivity within NPP departments. In contrast, individuals holding “Dean” title (e.g., Dean, Associate Dean, Assistant Dean) were excluded because these roles are primarily administrative in scope and typically involve substantially reduced or altered expectations for research productivity, which could confound analyses focused on faculty-level scholarly productivity. Faculty with Emeritus status were excluded because they do not represent active faculty appointments during the study period. Faculty listed in pharmacy practice, clinical pharmacy, pharmacotherapy, or other practice-based departments were excluded because the scope of this study was limited to NPP faculty within the BPS and SAS domains. Faculty and institutional characteristics Faculty-level variables collected included sex, disciplinary classification (BPS or SAS), academic rank (assistant professor, associate professor, or professor), department chair or head status, and terminal degree (PhD, PharmD, or other doctoral or professional degrees). Institutional characteristics were also recorded to capture the academic and research environment in which faculty operated. These included institution type (public or private), presence of graduate programs (MS, PhD, or other graduate degrees), affiliation with an HSC, U.S. geographic region (Northeast, Midwest, South, West, and U.S. territories), and institutional extramural research funding level (no funding reported, $1 to $100,000, $100,001 to $1,000,000, $1,000,001 to $6,000,000, or greater than $ 6,000,000). Institutional public or private designation and extramural research funding data were obtained from the AACP Funded Research Grant Institutional Tables.12 These tables provide aggregated annual grant data by institution, including funding from the National Institutes of Health (NIH), other federal sources, non-federal sources, and total funding from all grants.12 Funding data reflect information submitted to AACP and were accurate as of the time of AACP's data collection for each fiscal year.12 Publication data collection and verification Scholarly publications were identified using the Web of Science (WoS) database (Clarivate™, United Kingdom), a comprehensive, subscription-based research platform that indexes peer-reviewed research articles, reviews, books, editorials, letters, and conference proceedings across the sciences, social sciences, arts, and humanities.12 Each WoS record includes bibliographic information such as publication title, author names, abstracts, institutional affiliations and addresses, cited references, and document type, enabling detailed bibliometric analysis.12 The platform offers robust citation searching and analytical tools, enabling the tracking of research output and scholarly influence from 1900 to the present.12 The WoS database was selected as the sole bibliometric database to provide a standardized and reproducible approach to publication retrieval, document classification, and faculty-level publication counting across the large national sample. This approach is consistent with prior academic pharmacy bibliometric studies evaluating faculty scholarly productivity.5, 6, 7, 9 Faculty names were used as the primary search criterion, and the WoS advanced search interface was employed using specific field codes for author name, institutional affiliation, and publication year. All records retrieved by the study investigators (FF, MP, AE) through the search process were visually inspected to verify the author's exact first and last name (including middle initial when available), correct institutional affiliation, and publication type. Publications authored by more than one NPP faculty member—either within the same institution or across different institutions—were counted once for each eligible faculty member to avoid faculty bias. The publication counts in this study represent faculty-level publication counts rather than unique publications. Only records that met these criteria were included in the study dataset. Following the construction of the dataset, a multi-layered accuracy review was conducted. First, two investigators (MA, OS) independently reviewed a random 10% sample of publication records to confirm consistent application of the original inclusion, exclusion, and classification criteria. In addition, structured quality-control checks were performed by three investigators (OS, SP, AE) on a random 50% sample of faculty records to verify faculty publication count, type, and scope, with the sampling strategy designed to include at least one randomly selected faculty member from each school or college of pharmacy represented in the dataset. Differences identified during these reviews were infrequent and were resolved through discussion and consensus. Classification of publication type and scope Publications were classified by both type and scope. Publication types were defined using WoS publication categories and included original research articles, narrative reviews, systematic reviews, meta-analyses, editorials/book reviews/letters, books/book chapters, data papers/database reviews, and meeting abstracts/meeting summaries/proceedings papers. The publication scope was categorized into three mutually exclusive groups: BPS, SAS/health economics and outcomes research (HEOR)/clinical trials, and scholarship of teaching and learning (SoTL). Each publication was assigned to a single dominant scope category based on its primary scholarly focus. The rationale for this classification was to distinguish between laboratory-based and non-laboratory-based scholarly paradigms within NPP faculty, while also capturing education-focused scholarship as a distinct domain. This framework enabled scholarly productivity patterns to be interpreted in a manner that reflects fundamental differences in research approach and output across these domains. Statistical analysis Descriptive statistics were used to summarize faculty demographic and institutional characteristics. Categorical variables were reported as frequencies and percentages. Continuous variables were assessed for normality using the Shapiro-Wilk test and summarized using means with standard deviations and ranges or using medians with interquartile ranges (IQR), as appropriate. Scholarly productivity was quantified as the total number of publications per faculty member and as the annualized number of publications per faculty member per year. Due to the non-normative distribution of the data, comparisons of NPP faculty scholarly productivity across characteristics with two categories (e.g., sex, discipline, institution type, department chair or head status) were conducted using Mann–Whitney U tests, while comparisons across characteristics with more than two categories (e.g., academic rank, funding categories, geographic region) were conducted using Kruskal-Wallis test. When overall differences were observed, post hoc pairwise comparisons were performed using Dunn's test with Holm correction to adjust for multiple comparisons. The a priori level of significance was set at 0.05. All analyses were conducted using Stata® version 19.5 (StataCorp LLC, College Station, TX). Ethical considerations This study was deemed exempt by The University of Texas at Tyler Institutional Review Board review because it relied exclusively on publicly available data and did not involve direct interaction with human subjects. No individually identifiable information is reported. Results Faculty characteristics Data were collected from 1613 NPP faculty across 142 U.S. schools and colleges of pharmacy between January 1, 2019, and December 31, 2023, comprising 72 (50.7%) private institutions and 70 (49.3%) public institutions. Table 1 summarizes NPP demographic and institutional characteristics. The majority of faculty were male (67.4%), and most faculty (87.3%) were from the BPS disciplines, whereas 12.7% were from SAS. In terms of academic rank, 44% were professors, 38.1% associate professors, and 17.9% assistant professors. A small proportion (8%) of the faculty served as department chairs or heads.Table 1Characteristics of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613).Characteristicn (%)bSex Male1087 (67.4%) Female526 (32.6%)Discipline Biomedical and pharmaceutical sciences (BPS)a1408 (87.3%) Social and administrative sciences (SAS)205 (12.7%)Academic rank Assistant professor289 (17.9%) Associate professor615 (38.1%) Professor709 (44.0%)Department chair or head Yes129 (8.0%) No1484 (92.0%)Terminal degree PhD1552 (96.2%) PharmD47 (2.9%) Other degrees (MS, MD, other doctoral degrees)14 (0.9%)Institution type Public1042 (64.6%) Private571 (35.4%)Institution region Northeast276 (17.1%) South566 (35.1%) Midwest379 (23.5%) West385 (23.9%) Other U.S. territories7 (0.4%)Institution affiliation with a health science center Yes879 (54.5%) No734 (45.5%)Institution offers graduate programs Yes (MS, PhD, etc.)1110 (68.8%) No503 (31.2%)Institution average annual funding tier No funding reported73 (4.5%) $1 to $100,000149 (9.2%) $100,001 to $1,000,000274 (17.0%) $1,000,001 to $6,000,000365 (22.6%) >$ 6,000,000752 (46.6%)aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics.bPercentages may not total to 100% due to rounding. Table 1Characteristics of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613).Characteristicn (%)bSex Male1087 (67.4%) Female526 (32.6%)Discipline Biomedical and pharmaceutical sciences (BPS)a1408 (87.3%) Social and administrative sciences (SAS)205 (12.7%)Academic rank Assistant professor289 (17.9%) Associate professor615 (38.1%) Professor709 (44.0%)Department chair or head Yes129 (8.0%) No1484 (92.0%)Terminal degree PhD1552 (96.2%) PharmD47 (2.9%) Other degrees (MS, MD, other doctoral degrees)14 (0.9%)Institution type Public1042 (64.6%) Private571 (35.4%)Institution region Northeast276 (17.1%) South566 (35.1%) Midwest379 (23.5%) West385 (23.9%) Other U.S. territories7 (0.4%)Institution affiliation with a health science center Yes879 (54.5%) No734 (45.5%)Institution offers graduate programs Yes (MS, PhD, etc.)1110 (68.8%) No503 (31.2%)Institution average annual funding tier No funding reported73 (4.5%) $1 to $100,000149 (9.2%) $100,001 to $1,000,000274 (17.0%) $1,000,001 to $6,000,000365 (22.6%) >$ 6,000,000752 (46.6%)aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics.bPercentages may not total to 100% due to rounding. Characteristics of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613). BPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics. Percentages may not total to 100% due to rounding. Most faculty (96.2%) held a PhD as their terminal degree, while 2.9% held a PharmD, and 0.9% held another advanced degree (e.g., MS, MD, or other doctoral degree). A majority (64.6%) were employed at public institutions, and 54.5% were affiliated with an HSC. Most faculty (68.8%) were employed at institutions that offered graduate programs (MS/PhD). Faculty institutional extramural research funding levels were variable, with 46.6% having an average annual funding level of more than $6 million in NIH, other federal funding, or non-federal grants, while 4.5% of faculty were affiliated with institutions that reported no funding at all. Faculty were represented across all U.S. Census regions, with 35.1% of faculty based in the South, 23.9% in the West, 23.5% in the Midwest, 17.1% in the Northeast, and 0.4% in other U.S. territories. Overall publication productivity During the five-year study period, NPP faculty generated a diverse range of scholarly output (Table 2). The mean total publications per faculty was 17.15 ± 21.73 (median 10; IQR 4–23). The annualized rate per faculty was 3.43 ± 4.35 publications per year (median 2; IQR 0.8–4.6). Publication productivity was markedly skewed, with 15% of all faculty members producing 50% of all publications.Table 2Publication Activity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613).VariableMean (SD)RangeMedian (IQR)Total publications per faculty17.15 (21.73)0–28810 (4–23)Annualized publications per faculty3.43 (4.35)0–57.62 (0.8–4.6)Publication type per faculty per year Original research articles2.32 (3.03)0–34.21.2 (0.4–3) Meeting abstracts/summaries, proceedings papers0.57 (1.12)0–130.2 (0–0.6) Narrative reviews0.31 (0.71)0–17.40.2 (0–0.4) Editorials, book reviews, letters0.14 (0.38)0–7.20 (0–0.2) Books and book chapters0.05 (0.33)0–110 (0–0) Systematic reviews0.02 (0.13)0–2.60 (0–0) Meta-analyses0.02 (0.25)0–9.20 (0–0) Data papers and database reviews0.003 (0.05)0–1.80 (0–0)Publications scope per faculty per year BPSa2.49 (3.58)0–541.2 (0.2–3.2) SAS/HEOR/clinical trials0.87 (2.65)0–360 (0–0.4) SoTL0.07 (0.28)0–5.40 (0–0)Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HEOR, health economics and outcomes research; SoTL, scholarship of teaching and learning.aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics. Table 2Publication Activity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613).VariableMean (SD)RangeMedian (IQR)Total publications per faculty17.15 (21.73)0–28810 (4–23)Annualized publications per faculty3.43 (4.35)0–57.62 (0.8–4.6)Publication type per faculty per year Original research articles2.32 (3.03)0–34.21.2 (0.4–3) Meeting abstracts/summaries, proceedings papers0.57 (1.12)0–130.2 (0–0.6) Narrative reviews0.31 (0.71)0–17.40.2 (0–0.4) Editorials, book reviews, letters0.14 (0.38)0–7.20 (0–0.2) Books and book chapters0.05 (0.33)0–110 (0–0) Systematic reviews0.02 (0.13)0–2.60 (0–0) Meta-analyses0.02 (0.25)0–9.20 (0–0) Data papers and database reviews0.003 (0.05)0–1.80 (0–0)Publications scope per faculty per year BPSa2.49 (3.58)0–541.2 (0.2–3.2) SAS/HEOR/clinical trials0.87 (2.65)0–360 (0–0.4) SoTL0.07 (0.28)0–5.40 (0–0)Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HEOR, health economics and outcomes research; SoTL, scholarship of teaching and learning.aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics. Publication Activity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 1613). Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HEOR, health economics and outcomes research; SoTL, scholarship of teaching and learning. BPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics. Original research articles represented the dominant form of scholarly output, averaging 2.32 ± 3.03 publications per faculty per year (median 1.2; IQR 0.4–3), followed by meeting abstracts or proceedings (0.57 ± 1.12; median 0.2; IQR 0–0.6), narrative reviews (0.31 ± 0.71; median 0.2; IQR 0–0.4), and editorials or letters (0.14 ± 0.38; median 0; IQR 0–0.2). Other forms of scholarly productivity, including systematic reviews, meta-analyses, book chapters, and data papers, represented a relatively small proportion of the WoS-indexed publication records identified in this study. Most publications were in BPS, averaging 2.49 ± 3.58 per faculty per year (median 1.2; IQR 0.2–3.2), whereas SAS, HEOR, and clinical trial publications averaged 0.87 ± 2.65 per faculty per year (median 0; IQR 0–0.4). Publications in SoTL were infrequent, averaging 0.07 ± 0.28 per faculty per year (median 0; IQR 0–0). Fig. 1a and b show the distribution of the total number of publications produced by all NPP faculty in the study, categorized by type and scope of publications, respectively.Fig. 1Distribution of Non-Pharmacy Practice Faculty-Level Publication Counts by Type (1a) and Scope (1b) across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 27,659).Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HEOR, health economics and outcomes research; SoTL, scholarship of teaching and learning.Percentages are based on faculty-level publication counts rather than unique publications; publications authored by more than one eligible NPP faculty member were counted once for each eligible faculty member.Percentages may not total to 100% due to rounding.Fig. 1 Distribution of Non-Pharmacy Practice Faculty-Level Publication Counts by Type (1a) and Scope (1b) across U.S. Schools and Colleges of Pharmacy, 2019–2023 (N = 27,659). Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HEOR, health economics and outcomes research; SoTL, scholarship of teaching and learning. Percentages are based on faculty-level publication counts rather than unique publications; publications authored by more than one eligible NPP faculty member were counted once for each eligible faculty member. Percentages may not total to 100% due to rounding. Publication productivity by faculty and institutional characteristics Publication productivity varied across faculty and institutional characteristics (Table 3). Male faculty averaged 3.59 ± 4.6 publications per year (median 2; IQR 0.8–4.8), while female faculty averaged 3.1 ± 3.76 (median 1.8; IQR 0.6–4) publications per year. However, the difference in publication productivity between males and females was not statistically significant. (p = .089).Table 3Annualized Publication Productivity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy by Faculty Characteristics, 2019–2023 (N = 1613).CharacteristicnMean (SD)RangeMedian (IQR)p ValuebSex0.089 Male10873.59 (4.6)0–57.62 (0.8–4.8) Female5263.1 (3.76)0–29.21.8 (0.6–4)Discipline< 0.001 BPSa14085.13 (5.63)0–372.8 (1–7.8) SAS2053.18 (4.07)0–57.61.8 (0.6–4.2)Academic rank< 0.001 Assistant professor2892.96 (3.63)0–30.21.8 (0.6–3.8) Associate professor6152.75 (3.3)0–23.21.6 (0.6–3.6) Professor7094.21 (5.2)0–57.62.4 (1–5.8)Department chair or head0.084 Yes1294.27 (4.72)0–222.4 (0.8–6.8) No14843.36 (4.31)0–57.62 (0.6–4.6)Terminal degree0.092 PhD15523.42 (4.26)0–57.62 (0.8–4.6) PharmD473.68 (6.04)0–32.41.8 (0.4–3) Other degrees (MS, MD, other doctoral degrees)143.21 (7.08)0–27.20.9 (0–3)Institution type< 0.001 Public10424.37 (4.57)0–38.22.8 (1.4–6) Private5711.71 (3.26)0–57.60.8 (0.2–1.8)Institution region< 0.001 Northeast2762.89 (4.64)0–57.61.4 (0.4–3.7) South5663.28 (3.79)0–23.22 (0.8–4.2) Midwest3793.54 (4.09)0–29.22 (0.8–5) West3853.96 (5.06)0–38.22.4 (0.8–5.4) Other U.S. territories71.91 (2.84)0–80.8 (0–2.6)Institution affiliation with HSC< 0.001 Yes8794.04 (4.38)0–372.6 (1.2–5.8) No7342.69 (4.19)0–57.61.2 (0.4–3.2)Institution offers graduate programs< 0.001 Yes (MS, PhD, etc.)11104.03 (4.63)0–57.62.4 (1–5.6) No5032.11 (3.27)0–371 (0.4–2.6)Institution average annual funding tier< 0.001 No funding reported730.52 (0.57)0–20.4 (0–0.8) $1 to $100,0001491.44 (2.02)0–15.40.8 (0.4–1.8) $100,001 to $1,000,0002741.52 (1.98)0–161 (0.4–1.8) $1,000,001 to $6,000,0003652.96 (4.2)0–57.62 (0.8–3.8) >$ 6,000,0007525.03 (4.92)0–38.23.4 (1.6–7.2)Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HSC, health science center.aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics.bP-values derived from Mann–Whitney U or Kruskal–Wallis tests, as appropriate. Table 3Annualized Publication Productivity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy by Faculty Characteristics, 2019–2023 (N = 1613).CharacteristicnMean (SD)RangeMedian (IQR)p ValuebSex0.089 Male10873.59 (4.6)0–57.62 (0.8–4.8) Female5263.1 (3.76)0–29.21.8 (0.6–4)Discipline< 0.001 BPSa14085.13 (5.63)0–372.8 (1–7.8) SAS2053.18 (4.07)0–57.61.8 (0.6–4.2)Academic rank< 0.001 Assistant professor2892.96 (3.63)0–30.21.8 (0.6–3.8) Associate professor6152.75 (3.3)0–23.21.6 (0.6–3.6) Professor7094.21 (5.2)0–57.62.4 (1–5.8)Department chair or head0.084 Yes1294.27 (4.72)0–222.4 (0.8–6.8) No14843.36 (4.31)0–57.62 (0.6–4.6)Terminal degree0.092 PhD15523.42 (4.26)0–57.62 (0.8–4.6) PharmD473.68 (6.04)0–32.41.8 (0.4–3) Other degrees (MS, MD, other doctoral degrees)143.21 (7.08)0–27.20.9 (0–3)Institution type< 0.001 Public10424.37 (4.57)0–38.22.8 (1.4–6) Private5711.71 (3.26)0–57.60.8 (0.2–1.8)Institution region< 0.001 Northeast2762.89 (4.64)0–57.61.4 (0.4–3.7) South5663.28 (3.79)0–23.22 (0.8–4.2) Midwest3793.54 (4.09)0–29.22 (0.8–5) West3853.96 (5.06)0–38.22.4 (0.8–5.4) Other U.S. territories71.91 (2.84)0–80.8 (0–2.6)Institution affiliation with HSC< 0.001 Yes8794.04 (4.38)0–372.6 (1.2–5.8) No7342.69 (4.19)0–57.61.2 (0.4–3.2)Institution offers graduate programs< 0.001 Yes (MS, PhD, etc.)11104.03 (4.63)0–57.62.4 (1–5.6) No5032.11 (3.27)0–371 (0.4–2.6)Institution average annual funding tier< 0.001 No funding reported730.52 (0.57)0–20.4 (0–0.8) $1 to $100,0001491.44 (2.02)0–15.40.8 (0.4–1.8) $100,001 to $1,000,0002741.52 (1.98)0–161 (0.4–1.8) $1,000,001 to $6,000,0003652.96 (4.2)0–57.62 (0.8–3.8) >$ 6,000,0007525.03 (4.92)0–38.23.4 (1.6–7.2)Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HSC, health science center.aBPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics.bP-values derived from Mann–Whitney U or Kruskal–Wallis tests, as appropriate. Annualized Publication Productivity of Non-Pharmacy Practice Faculty across U.S. Schools and Colleges of Pharmacy by Faculty Characteristics, 2019–2023 (N = 1613). Abbreviations: BPS, biomedical and pharmaceutical sciences; SAS, social and administrative sciences; HSC, health science center. BPS includes biological sciences, biomedical sciences, medicinal/pharmaceutical chemistry, pharmacognosy, pharmaceutics, pharmacology/toxicology, pharmacokinetics/pharmacodynamics, and pharmacogenetics. P-values derived from Mann–Whitney U or Kruskal–Wallis tests, as appropriate. BPS Faculty demonstrated higher publication productivity than SAS faculty. BPS faculty averaged 5.13 ± 5.63 publications per year (median 2.8; IQR 1–7.8), while SAS faculty averaged 3.18 ± 4.07 (median 1.8; IQR 0.6–4.2) publications per year. The difference between the two groups was statistically significant (p < .001). Publication productivity varied by academic rank. Assistant professors averaged 2.96 ± 3.63 publications per year (median 1.8; IQR 0.6–3.8), associate professors 2.75 ± 3.3 (median 1.6; IQR 0.6–3.6), and professors 4.21 ± 5.2 (median 2.4; IQR 1–5.8). Professors had significantly higher publication productivity than both assistant and associate professors (p < .001), while the difference between assistant and associate professors was not significant (p = .279). Those serving as department chairs averaged 4.27 ± 4.72 publications per year (median 2.4; IQR 0.8–6.8), compared with 3.36 ± 4.31 (median 2; IQR 0.6–4.6) among non-chairs; this difference was not statistically significant (p = .084). When examined by terminal degree, individuals with a PhD averaged 3.42 ± 4.26 publications per year (median 2; IQR 0.8–4.6), those with a PharmD averaged 3.68 ± 6.04 (median 1.8; IQR 0.4–3), and those with other graduate or professional degrees averaged 3.21 ± 7.08 (median 0.9; IQR 0–3). No significant differences were observed across degree categories (p = .092). Faculty at public institutions averaged 4.37 ± 4.57 publications per year (median 2.8; IQR 1.4–6), while those at private institutions averaged 1.71 ± 3.26 (median 0.8; IQR 0.2–1.8). Publication productivity was significantly higher among faculty at public institutions (p < .001). Publication productivity differed significantly across U.S. regions (p < .001). Faculty in the Northeast averaged 2.89 ± 4.64 publications per year (median 1.4; IQR 0.4–3.7), compared with 3.28 ± 3.79 (median 2; IQR 0.8–4.2) in the South, 3.54 ± 4.09 (median 2; IQR 0.8–5.0) in the Midwest, and 3.96 ± 5.06 (median 2.4; IQR 0.8–5.4) in the West. Post hoc comparisons indicated that faculty in the Northeast had significantly lower publication productivity than those in the South (p = .046), Midwest (p = .005), and West (p < .001). Differences among the South, Midwest, and West were not statistically significant, nor were comparisons involving other U.S. territories. Affiliation with an HSC was also associated with greater output. Faculty at institutions affiliated with an HSC averaged 4.04 ± 4.38 publications per year (median 2.6; IQR 1.2–5.8), compared with 2.69 ± 4.19 (median 1.2; IQR 0.4–3.2) for those at institutions not affiliated with an HSC, and the difference was statistically significant (p < .001). Those at institutions offering graduate programs had higher publication productivity, averaging 4.03 ± 4.63 publications per year (median 2.4; IQR 1–5.6), compared with 2.11 ± 3.27 (median 1; IQR 0.4–2.6) among those at institutions without such programs. This difference was statistically significant (p < .001). Publication productivity varied significantly across institutional extramural research funding levels (p < .001). Faculty at institutions reporting no research funding averaged 0.52 ± 0.57 publications per year (median 0.4; IQR 0–0.8), whereas those at institutions with more than $6 million in annual research funding averaged 5.03 ± 4.92 (median 3.4; IQR 1.6–7.2). Post hoc comparisons revealed that institutions with no reported funding had significantly lower publication productivity than those with any other funding tier (p < .001). Scholarly productivity also increased progressively with higher funding levels, showing significant differences between all adjacent tiers except between the $1–$100,000 and $100,001–$1,000,000 categories (p = .326). Faculty at institutions with more than $6 million in annual research funding exhibited the highest publication productivity, significantly exceeding all other groups (p < .001). Discussion This national study of 1613 NPP faculty across 142 U.S. schools and colleges of pharmacy provides an updated benchmark for scholarly productivity among BPS and SAS faculty. Publication productivity differed significantly across the institutional characteristics of faculty members but not across individual factors such as sex or terminal degree, suggesting that research infrastructure and environment have a stronger influence on scholarly output than personal attributes. Across all NPP faculty, the mean total publication count was 17.15 ± 21.73 (median 10; IQR 4–23), corresponding to an annualized rate of 3.43 ± 4.35 publications per faculty per year (median 2; IQR 0.8–4.6). These findings indicate substantially greater productivity than that observed among pharmacy practice faculty. For example, Chisholm-Burns et al. (2012) reported 0.51 ± 0.4 per faculty per year (median 0.41) over five years across 90 schools.2 Our reported publication productivity was also higher than the self-reported, cross-sectional analysis of publication productivity by Hight et al. (2020) among U.S. pharmacy faculty in 209 institutions (2 ± 2.1 publications per faculty member per year).3 Similarly, Urry et al. (2023) reported 9.3 ± 16.3 papers published over ten years among 2147 tenure-track pharmacy practice faculty, which is lower than the average total publication productivity reported in our study over five years.1 In contrast, Thompson and Harrison (2005) found that basic science pharmacy faculty in research-intensive U.S. colleges of pharmacy had a mean of 3.6 ± 4.25 publications per year between 1999 and 2003, which is similar to the publication rate in our study.6 Similarly, Thompson and Nahata (2012) evaluated the publication records of pharmaceutical science faculty at research-intensive institutions between 2005 and 2009, reporting a median of 2 (range, 0–34) publications per faculty per year.7 This finding is consistent with the publication productivity observed in our study. Overall, these comparisons highlight a notable disparity in scholarly productivity across faculty types, with NPP faculty contributing disproportionately more to pharmacy scholarship than their pharmacy practice counterparts. Publication productivity in this national NPP cohort was highly concentrated, with 15% of faculty producing 50% of all publications over the five-year period. This pattern is interestingly consistent with earlier work by Thompson and Harrison (2005), who reported that approximately 15% of basic science pharmacy faculty generated half of all publications in their sample from 1999 to 2003.6 Similarly, Thompson and Nahata (2012) found that 15% of pharmaceutical sciences faculty at research-intensive institutions accounted for 50% of total publications between 2005 and 2009.7 The convergence of these findings across different time periods, sampling frames, and analytical approaches suggests that a highly concentrated distribution of scholarly output—where a relatively small subset of faculty is responsible for a disproportionate share of publications—is a stable feature of pharmaceutical and basic science scholarship in U.S. schools and colleges of pharmacy. In the context of the present study, which includes faculty from all institution types and both BPS and SAS disciplines, this concentration likely reflects systematic differences in access to research infrastructure, funded projects, collaborators, and protected time rather than individual productivity alone. Understanding the institutional conditions that enable high faculty productivity may help inform strategies to broaden research capacity and support a larger proportion of NPP faculty in sustaining their scholarly output. Across the national NPP sample, original research articles constituted the largest proportion of publications (67.7%), followed by meeting abstracts and proceedings papers (16.6%), narrative reviews (8.9%), editorials, book reviews, and letters (4.2%), with all other categories contributing relatively small proportions. This distribution closely mirrors patterns previously observed in pharmaceutical sciences faculty. In non-research-intensive settings, Bloom and Schlesselman (2015) found that articles accounted for 70.6% of publications, followed by abstracts (12.4%) and reviews (9.3%), with all other publication types contributing less than 3% each.8 Similarly, Thompson and Nahata (2012) reported that among research-intensive pharmaceutical sciences faculty, two-thirds (67%) of publications were articles, 19% were abstracts, 6% reviews, 4% proceedings, with all other publication types contributing 2% or less each.7 These consistent patterns across institution types—research-intensive and non-research-intensive alike—demonstrate that original research articles remain the dominant form of scholarly output in pharmaceutical sciences and related fields, while posters, abstracts, and reviews serve as secondary modes of dissemination. Over the five-year period, publications with a BPS scope accounted for 72.5% of all publications, compared with 25.5% in SAS, HEOR, and clinical trials, while SoTL comprised 2.1%. Although prior studies have not categorized scholarly productivity by scope in precisely the same way, their discipline-level findings allow for broad comparison. Thompson and Nahata (2012), for example, reported that the cumulative publication output at research-intensive institutions was distributed such that medicinal chemistry, pharmaceutics, and pharmacology each accounted for approximately one-quarter of publications, with SAS comprising the remaining quarter.7 When viewed cumulatively, their results approximate a 75%–25% split between laboratory-based BPS and SAS—closely mirroring the 72.5%–25.5% distribution observed in the current national NPP cohort.7 This suggests that, across different classification approaches and institutional contexts, scholarly output tends to concentrate more heavily in BPS-oriented fields than in SAS-related areas. The interpretation of these scope patterns should be considered in relation to the composition of the NPP faculty workforce. In this national sample, 87.3% of faculty were from BPS disciplines, whereas 12.7% were from SAS. In this context, the overall distribution of publication scope likely reflects the underlying disciplinary makeup of the NPP workforce rather than differences in scholarly emphasis or value. Accordingly, the predominance of BPS-related scholarly productivity at the national level is influenced in part by the numerical dominance of BPS faculty. In this nationally representative analysis, publication productivity did not differ between males and females among NPP faculty. Prior work in NPP disciplines has not examined research output by sex, leaving no established benchmark for comparison. The lack of a difference in our study suggests that sex may not be associated with scholarly productivity in these fields. Instead, productivity among NPP faculty is likely shaped predominantly by other faculty characteristics and the institutional environments in which they work—such as research capacity, funding support, and program structure—factors that showed clearer associations in our analysis. Faculty in the BPS discipline published more (mean 5.13 ± 5.63; median 2.8; IQR 1–7.8) than those in SAS (mean 3.18 ± 4.07; median 1.8; IQR 0.6–4.2; p < .001). These values are notably higher than those reported in prior studies in non-research-intensive institutions. For example, Bloom and Schlesselman (2015) found an average of 0.82 publications per year for pharmaceutical sciences faculty across four years at non-research-intensive institutions, while Weathers and Unni (2018) reported 0.92 publications per year over five years for SAS faculty at similarly non-research-intensive programs.8, 9 The higher publication rates observed in our study likely reflect differences in scope and institutional representation. Unlike earlier studies, ours includes research-intensive institutions where faculty typically have stronger research expectations, greater infrastructure, and more robust funding support, leading to higher scholarly productivity. Additionally, our larger and more contemporary dataset provides a more comprehensive estimate of current national research productivity, further contributing to the observed differences. The differences in average publication productivity between BPS and SAS should be interpreted cautiously. Although both groups fall under the NPP umbrella in this study, they represent distinct scholarly domains that often operate within different research environments. Variations in research infrastructure, funding support, availability of graduate trainees, and institutional expectations for scholarly productivity may all contribute to observed differences in publication volume. As such, lower average publication rates among SAS faculty do not necessarily imply lesser scholarly contribution but rather reflect structural and contextual factors that complicate direct, uniform comparisons across disciplines. These findings underscore the importance of discipline-sensitive benchmarks when evaluating scholarly productivity among NPP faculty. Publication productivity increased progressively with academic rank: assistant professors averaged 2.96 ± 3.63 (median 1.8; IQR 0.6–3.8), associate professors 2.75 ± 3.3 (median 1.6; IQR 0.6–3.6), and professors 4.21 ± 5.2 (median 2.4; IQR 1–5.8), with professors exhibiting markedly higher output than assistant and associate professors (p < .001). Notably, publication productivity did not significantly differ between assistant and associate professors. This pattern, where the primary distinction is between full professors and the two junior academic ranks rather than between assistant and associate ranks, is consistent with prior findings in the NPP faculty scholarly productivity literature. Thompson and Harrison (2005) reported a similar gradient in basic science pharmacy faculty from research-intensive institutions (assistant professors 2.59 ± 2.7; associate professors 2.75 ± 2.85; professors 4.77 ± 5.29 publications per year), where professors published more than both assistant and associate professors, but the difference between assistant and associate ranks was not significant.6 Likewise, Thompson and Nahata (2012) evaluated publication productivity among pharmaceutical science faculty at research-intensive institutions and found that professors had a higher number of publications per faculty per year (mean 4.6, median 3) than both associate (mean 2.7, median 2) and assistant professors (mean 2.7, median 2), with no differences between assistant and associate professors.7 These findings suggest that academic rank captures broad career-stage differences in scholarly productivity but may not fully account for underlying structural variations within ranks. Rank alone does not distinguish between tenured, tenure-track, and non-tenure-track appointments within NPP departments. Expectations for scholarly productivity may differ across these appointment types—even among faculty at the same rank—and such differences could contribute to the heterogeneity observed within rank categories. Future studies that explicitly differentiate faculty by appointment track may provide additional insight into how institutional expectations and career structures shape long-term scholarly productivity among NPP faculty. When publication productivity was analyzed based on the department chair or head status, we found no significant difference between chairs and non-chairs. Specifically, chairs published an average of 4.27 ± 4.72 articles per year compared to 3.36 ± 4.31 for non-chairs, with a median of 2.4 (IQR 0.8–6.8) for chairs vs 2.0 (IQR 0.6–4.6) for non-chairs (p = .084). These results contrast with those of Thompson et al. (2012), who found that chairs in research-intensive pharmacy programs had a higher publication output per faculty per year compared to non-chairs (mean 3.3 vs 2.3; median 2.0 vs 1.0; p < .01).7 They attributed this difference largely to rank distribution, noting that 86% of the chairs in their study were full professors and only 1% were assistant professors, making chair status a proxy for seniority in academic rank.7 In our nationally representative sample, chairs were still mostly senior faculty but exhibited a more balanced rank distribution (5.4% assistant professors, 29.5% associate professors, and 65.1% professors). Additionally, because our study encompassed all types of institutions—not only research-intensive programs—the structural overlap between chair status, research expectations, and scholarly productivity was less pronounced. These features of our broader sample may explain why publication productivity did not differ between chairs and non-chairs in our study. By contrast, publication productivity differed substantially and consistently across faculty members’ institutional characteristics. Faculty at public institutions averaged 4.37 ± 4.57 publications per year (median 2.8; IQR 1.4–6.0), more than double the output of faculty at private institutions (1.71 ± 3.26; median 0.8; IQR 0.2–1.8; p < .001). These findings contrast with those of Bloom and Schlesselman (2015), who reported no differences in publication rates between public and private institutions among pharmaceutical sciences faculty at non-research-intensive institutions.8 The broader historical literature, however, suggests that differences by institution type are not a new phenomenon. Mathys et al. (2000) reported a clear and persistent public–private gap over a 22-year period, with public schools and colleges of pharmacy consistently producing significantly more publications per faculty per year than private institutions (p < .05 across all years).13 The differences in findings across studies likely reflect variations in sampling frames and institutional contexts. Our study examined a nationally representative sample that included a broad range of universities, many of which are research-intensive public institutions. Public universities typically possess stronger research infrastructure, higher expectations for securing extramural funding, larger and more established graduate programs, and more extensive laboratory and data resources—factors that collectively support higher levels of scholarly productivity. In contrast, Bloom and Schlesselman (2015) focused exclusively on non-research-intensive environments, where public and private institutions may operate under more similar research conditions.8 Taken together, these findings suggest that the association between institution type and NPP scholarly productivity reflects differences in institutional research capacity rather than public or private status alone. Regional differences in publication productivity were also observed. Faculty in the Northeast demonstrated lower annual publication output than those in the South, Midwest, and West, whereas the latter three regions exhibited broadly comparable levels of productivity. Differences involving other U.S. territories were negligible, likely reflecting their limited representation in the sample (0.4%) and insufficient statistical power to detect meaningful differences. These findings contrast with Bloom and Schlesselman (2015), who reported no regional differences in publication productivity among pharmaceutical sciences faculty.8 However, their study was restricted to non-research-intensive institutions and did not include SAS faculty, resulting in a sample that lacked the institutional diversity needed to detect regional differences. In contrast, the present study included faculty across the full spectrum of institution types, including research-intensive institutions with graduate programs and substantial funded research activity. Accordingly, the regional differences observed here may reflect variation in institutional research capacity and funding environments across regions, rather than geographic location alone. Affiliation with an HSC was associated with higher scholarly productivity in the present study. Faculty at HSC-affiliated institutions published 4.04 ± 4.38 publications per year (median 2.6; IQR 1.2–5.8), compared with 2.69 ± 4.19 (median 1.2; IQR 0.4–3.2) among those at non-affiliated institutions (p < .001). Prior work involving NPP faculty shows a mixed pattern. Weathers and Unni (2018) examined only SAS faculty at non-research-intensive pharmacy schools and found that being part of an academic health center was a significant predictor of faculty publication productivity.9 Although SAS scholarly activities are typically not laboratory-based, SAS faculty often pursue collaborative, interdisciplinary, and data-driven research. Academic HSC environments may support this work through access to health-system data, established processes for human subject research oversight, and organizational proximity to clinical, administrative, and policy partners. Bloom and Schlesselman (2015), however, found no association between HSC affiliation and publication productivity among pharmaceutical sciences faculty.8 Their analysis was limited to non-research-intensive institutions and did not include SAS faculty.8 Additionally, only 15.3% of the 59 schools they examined were HSC-affiliated, compared with 44.4% of institutions in the present national sample.8 In such constrained environments, differences in research capacity between HSC-affiliated and standalone schools may be less distinct. Earlier work by Mathys and Thompson (2000), although not specific to NPP faculty, also showed consistently higher publication productivity among HSC-based institutions, with HSC-affiliated schools outperforming non-HSC schools in 20 of the 22 years examined.13 These findings suggest that the influence of HSC affiliation on scholarly output is shaped by several contextual factors, including the institution's overall research capacity, the disciplinary composition of the faculty, and the organizational or collaborative supports embedded within HSC environments. These mechanisms, rather than laboratory infrastructure alone, likely contribute to the more pronounced HSC-related differences observed in the nationally representative cohort analyzed in the present study. Similarly, institutions offering graduate programs (e.g., MS/PhD) had significantly higher publication output, with faculty at these institutions averaging 4.03 ± 4.63 publications per year (median 2.4; IQR 1–5.6), compared with 2.11 ± 3.27 (median 1.0; IQR 0.4–2.6) among those at institutions without graduate programs (p < .001). These findings parallel the results of Bloom and Schlesselman (2015), who reported that pharmaceutical sciences departments offering a PhD produced an additional 0.45 publications per faculty member per year compared with departments without a PhD program.8 Their analysis, although limited to non-research-intensive schools, suggests that graduate education is an important structural contributor to scholarly output.8 The presence of graduate students and research trainees likely expands faculty research capacity, enabling larger and more complex projects, increasing opportunities for co-authorship, and contributing to a more active and sustainable research environment. Institutions with graduate programs may also have stronger expectations for scholarly productivity and more established research infrastructure, which together help explain the higher productivity observed in the present study. Research funding was also associated with publication productivity in our study. Faculty at institutions reporting no external research funding had the lowest output, averaging 0.52 ± 0.57 publications per faculty per year (median 0.4; IQR 0–0.8). Productivity increased among institutions with $1–$100,000 and $100,001–$1,000,000 in annual research support, rose further at institutions with $1,000,001–$6,000,000, and was highest at institutions exceeding $6 million annually, where faculty averaged 5.03 ± 4.92 publications per faculty per year (median 3.4; IQR 1.6–7.2). Pairwise comparisons demonstrated clear stepwise differences across nearly all adjacent funding categories, indicating that institutional research investment is meaningfully related to scholarly output for NPP faculty. These findings can be compared with two key studies examining NPP faculty scholarly productivity in non-research-intensive settings. Bloom and Schlesselman (2015), focusing exclusively on pharmaceutical sciences departments at non-research-intensive institutions, found that NIH-funded departments produced 0.42 more publications per faculty member per year than those without NIH funding (p = .006).8 Although their analysis centered solely on NIH support, the directional relationship is similar.8 In contrast, Weathers and Unni (2018), studying SAS faculty in non-research-intensive schools, modeled publication output using total research funding and funding status (funded vs not funded) and found that neither variable predicted scholarly productivity.9 This difference may reflect disciplinary distinctions: SAS scholarly productivity is typically less dependent on large-scale research infrastructure and may derive comparatively less benefit from high funding levels than BPS, which dominate the NPP cohort in the present study. The divergence may also arise from broader institutional representation and a more diverse level of research intensity in the current national sample. In contrast, Weathers and Unni's analysis focused solely on non-research-intensive environments, where funding disparities might have a lesser impact.9 Overall, the present results indicate that institutional extramural research support is closely aligned with publication productivity in nationally representative NPP departments. The pattern suggests that research investment contributes to the capacity for sustained scholarly output, likely through expanded infrastructure, collaborative opportunities, and the availability of research personnel and trainees. Limitations This study has several limitations that should be considered when interpreting the findings. First, publication data were obtained exclusively from the WoS database, a widely used and well-established bibliographic database in studies evaluating faculty scholarly productivity. Although inclusion of additional databases, such as Scopus, may have identified additional publications because of differences in journal coverage, indexing practices, update frequency, and document classification, the use of a single standardized database improved methodological consistency, reproducibility, deduplication accuracy, and uniform document classification across the large national sample examined in this study. This limitation may be especially relevant for publication types such as book chapters and other non-journal scholarly works, which may be underrepresented in WoS compared with other bibliometric databases such as Scopus. Similar database-dependent approaches have been used in prior national and discipline-specific studies of faculty research productivity.1, 2, 4, 5, 6, 7, 8, 9, 13, 14 Importantly, the inclusion of a large, nationally representative cohort and a five-year observation period enhances the robustness of the findings and reduces the likelihood that any incomplete indexing would meaningfully influence overall trends or comparisons across faculty and institutional characteristics. Second, as with other large-scale bibliometric analyses, author-name disambiguation presents inherent challenges. Despite the application of systematic verification procedures, some publications may have been misattributed or omitted, particularly for faculty with common surnames, inconsistent name usage, or name changes over time. Similar challenges have been acknowledged in previous studies assessing pharmacy practice and the scholarly productivity of NPP faculty.1, 6, 7, 9, 14, 15 Third, faculty were identified using the AACP Roster of Faculty and Professional Staff, as well as publicly available institutional websites.10 While these sources represent the most comprehensive national repositories available, they may contain delayed updates or inconsistencies in reporting faculty rank, title, degrees, or departmental affiliation. Comparable limitations associated with roster-based data have been noted in prior studies using AACP-derived faculty listings.8, 16 Fourth, scholarly productivity was assessed using publication counts, which do not capture additional dimensions of scholarly productivity such as citation impact, authorship position, journal quality, or collaborative scope. Nevertheless, publication volume remains a foundational and widely accepted benchmark for describing scholarly productivity at the national level and has been used consistently in prior faculty research productivity studies.1, 6, 7, 9, 13 Within this context, the present study provides an important baseline characterization of NPP faculty scholarly productivity across U.S. schools and colleges of pharmacy, offering a framework for future investigations incorporating more nuanced bibliometric indicators. Fifth, the descriptive and observational nature of the analysis precludes causal inference. Although publication productivity varied across several institutional characteristics—such as research funding levels, graduate program offerings, and HSC affiliation—these factors may coexist with other unmeasured influences, including institutional research culture, workload distribution, or internal expectations for scholarly productivity. Similar interpretive considerations have been discussed in prior benchmarking studies of faculty productivity.8, 9 Sixth, faculty rank was treated as a static characteristic across the study period. Because promotions may have occurred during the five-year window, some publications may have been attributed to a faculty member's rank at the end of the observation period rather than the rank held at the time of publication. Rank-related misclassification has been recognized as a common challenge in longitudinal studies of faculty research productivity.1 Seventh, the organizational placement of SAS faculty within U.S. schools and colleges of pharmacy is not uniform. Depending on institutional structure, SAS faculty may be housed within BPS units, pharmacy practice departments, or independent SAS units. In the present study, faculty members were classified as SAS based on the AACP Roster of Faculty and Professional Staff.10 Although this approach was intended to accurately reflect scholarly focus, some limited degree of misclassification may still have occurred for faculty whose roles span multiple domains (e.g., SAS and pharmacy practice). Finally, the observation period (2019–2023) substantially overlapped with the coronavirus disease 2019 (COVID-19) pandemic and the federal public health emergency declaration in the United States, which may have influenced academic workflows, research activities, publication timelines, and dissemination patterns in uneven ways across institutions and disciplines. Therefore, comparisons with studies conducted before, during, or after this period should be interpreted with consideration of this unique timeframe. Despite this contextual consideration, the overall patterns observed in this analysis were generally comparable to those reported in prior NPP studies conducted during pre-pandemic periods. Conclusion This national analysis provides a comprehensive and contemporary characterization of scholarly productivity among NPP faculty across U.S. schools and colleges of pharmacy. Using faculty-level publication data over a five-year period, this study establishes current national benchmarks for publication volume, type, and scope across BPS and SAS disciplines. Publication productivity varied substantially across both faculty and institutional characteristics. Differences were observed by disciplinary area and academic rank and were also evident across institutional factors, including public versus private status, geographic region, affiliation with an HSC, the presence of graduate programs, and levels of extramural research funding. In contrast, publication productivity did not differ by faculty sex or terminal degree. Together, these benchmarks provide a national reference framework for evaluating NPP scholarly productivity and may inform faculty annual evaluations, promotion and tenure processes, faculty development initiatives, departmental planning, and institutional assessment efforts. Future research may build on these findings by examining broader dimensions of scholarly impact, additional factors influencing productivity, and evolving expectations for research productivity in pharmacy education. Data statement The data used in this study were compiled from multiple sources and curated by the authors. The compiled dataset includes identifiable information at the individual faculty level. Aggregated data supporting the findings of this study may be made available by the corresponding authors upon reasonable request. CRediT authorship contribution statement Osama A. Shoair: Writing – review & editing, Writing – original draft, Visualization, Validation, Supervision, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Sierra Pollard: Writing – review & editing, Writing – original draft, Validation, Investigation, Formal analysis. Faith Fosuhene-Apenteng: Writing – review & editing, Writing – original draft, Validation, Investigation. Michael Pimentel-Galvan: Writing – review & editing, Validation, Investigation, Formal analysis. Abrar Elagami: Writing – review & editing, Validation, Investigation. May H. Abdel Aziz: Writing – review & editing, Validation, Supervision, Project administration, Methodology, Investigation, Conceptualization. Ethics approval and consent to participate This study was deemed exempt by The University of Texas at Tyler Institutional Review Board review because it relied exclusively on publicly available data and did not involve direct interaction with human subjects. No individually identifiable information is reported. Funding/support None declared. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.